Bayer Aktiengesellschaft (BAYZF)

50.39 -2.17 (-4.12%) At close: 10:04AM EDT

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
https://www.bayer.com

Sector(s): Healthcare
Industry: Drug Manufacturers—General
Full-time employees: 102,048

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Wolfgang U. Nickl	CFO & Member of Management Board	2.27M	N/A	1969
Mr. Heiko W. J. Schipper	Member of Management Board & Pres of the Consumer Health Division	2.05M	N/A	1969
Mr. Stefan Oelrich	Head of the Pharmaceuticals Division & Member of the Board of Management	2.22M	N/A	1968
Mr. Rodrigo Santos	Member of Management Board & Pres of the Crop Science Division	2.31M	N/A	1973
Mr. William N. Anderson	Chairman of the Management Board & CEO	N/A	N/A	1966
Ms. Heike Prinz	Chief Talent Officer, Labor Director & Member of Management Board	N/A	N/A	1965
Mr. Bernd-Peter Bier	Head of Accounting and Head of Taxes	N/A	N/A	1967
Mr. Oliver Maier	Head of Investor Relations	N/A	N/A	N/A
Dr. Gabriel Harnier	Head of Law, Patents & Compliance	N/A	N/A	1971
Mr. Michael Preuss	Head of Communications, Gov. Relations and Corp. Brand	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases, as well as collaboration with Bicycle Therapeutics to develop bicyclic peptides. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Corporate governance

Bayer Aktiengesellschaft’s ISS governance QualityScore as of 1 September 2023 is 6. The pillar scores are Audit: 10; Board: 2; Shareholder rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.